methylphenazonium methosulfate has been researched along with Leukemia, Prolymphocytic, T-Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geyeregger, R; Jäger, U; Kiefer, FW; Porpaczy, E; Shehata, M; Stuhlmeier, KM; Stulnig, TM; Zeyda, M; Zlabinger, GJ | 1 |
1 other study(ies) available for methylphenazonium methosulfate and Leukemia, Prolymphocytic, T-Cell
| Article | Year |
|---|---|
Liver X receptors interfere with cytokine-induced proliferation and cell survival in normal and leukemic lymphocytes.
Topics: Antigens, CD; Cell Division; Cell Survival; Cholesterol; Cytokines; Humans; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Prolymphocytic, T-Cell; Lipids; Liver X Receptors; Lymphocytes; Methylphenazonium Methosulfate; Orphan Nuclear Receptors; T-Lymphocytes | 2009 |